The United States Patent and Trademark Office (USPTO) has renewed the trademark TM97385879, known as 'Shomool,' for a range of medical services. These services include consultancy in the medical diagnosis of autosomal recessive disorders, genetic testing for medical purposes, healthcare provision, medical diagnosis of autosomal recessive disorders, medical testing for diagnostic or treatment purposes, and performing disease diagnosis. The renewal is effective March 22, 2026.

This renewal signifies the continued protection of the 'Shomool' trademark for these specific medical services. While this is a trademark renewal and not a new regulatory requirement, companies operating in the prenatal diagnosis and genetic testing space should be aware of existing trademark protections. No new compliance actions are mandated by this renewal, but it reinforces the importance of intellectual property management in the healthcare sector.